BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7910962)

  • 21. Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci.
    Li F; Szobor A; Croxen R; Anselmo V; Yuan QP; Lindblad K; Schalling M; Komoly S; Beeson D; Larsson C
    Int J Mol Med; 2001 Mar; 7(3):289-94. PubMed ID: 11179509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.
    Oksenberg JR; Sherritt M; Begovich AB; Erlich HA; Bernard CC; Cavalli-Sforza LL; Steinman L
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):988-92. PubMed ID: 2915992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal cell derived factor-1 genetic variation at locus 801 in patients with myasthenia gravis.
    Yousefipour GA; Haghshenas MR; Yahyazadeh S; Erfani N
    Iran J Immunol; 2011 Jun; 8(2):90-5. PubMed ID: 21705836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrogen receptor alpha gene intronic polymorphisms and autoimmune myasthenia gravis in Caucasian women.
    Pal Z; Gal A; Remenyi V; Tordai A; Molnar MJ
    Neuromuscul Disord; 2009 Dec; 19(12):822-4. PubMed ID: 19793653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
    MacLennan C; Beeson D; Buijs AM; Vincent A; Newsom-Davis J
    Ann Neurol; 1997 Apr; 41(4):423-31. PubMed ID: 9124798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.
    Nichols P; Croxen R; Vincent A; Rutter R; Hutchinson M; Newsom-Davis J; Beeson D
    Ann Neurol; 1999 Apr; 45(4):439-43. PubMed ID: 10211467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Polymorphisms for Both Auto-antigen and Immune-Modulating Proteins Are Associated with the Susceptibility of Autoimmune Myasthenia Gravis.
    Li HF; Hong Y; Zhang X; Xie Y; Skeie GO; Hao HJ; Gilhus NE; Liang B; Yue YX; Zhang XJ; Gao X; Wang Q; Gao Z; Ding XJ; Song M
    Mol Neurobiol; 2017 Aug; 54(6):4771-4780. PubMed ID: 27501803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy.
    Ahlsten G; Lefvert AK; Osterman PO; Stålberg E; Säfwenberg J
    J Child Neurol; 1992 Jul; 7(3):264-9. PubMed ID: 1634748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
    Chen Y; Wang W; Wei D; Yang L
    Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.
    Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of TNF-α gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population.
    Yang HW; Lei P; Xie YC; Han ZL; Li D; Wang SH; Sun ZL
    Cancer Gene Ther; 2017 Jun; 24(6):259-266. PubMed ID: 28429750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis.
    Hossann M; Li Z; Shi Y; Kreilinger U; Büttner J; Vogel PD; Yuan J; Wise JG; Trommer WE
    Protein Expr Purif; 2006 Mar; 46(1):73-84. PubMed ID: 16230023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited predisposition to myasthenia gravis in Newfoundlands.
    Lipsitz D; Berry JL; Shelton GD
    J Am Vet Med Assoc; 1999 Oct; 215(7):956-8, 946. PubMed ID: 10511859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
    Biesecker G; Koffler D
    J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis.
    Bonifati DM; Willcox N; Vincent A; Beeson D
    Muscle Nerve; 2004 Mar; 29(3):436-9. PubMed ID: 14981744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases.
    Murray EL; Kedar S; Vedanarayanan VV
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):76-9. PubMed ID: 21386774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune myasthenia gravis in two brothers.
    Khadilkar SV; Shah SV
    J Assoc Physicians India; 2004 Mar; 52():253-4. PubMed ID: 15636322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.
    Nikolic AV; Andric ZP; Simonovic RB; Rakocevic Stojanovic VM; Basta IZ; Bojic SD; Lavrnic DV
    Eur J Neurol; 2015 Jan; 22(1):59-63. PubMed ID: 25070808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.